Bionano Genomics, Inc. (NASDAQ:BNGO) has seen 3,393,341 shares traded in the recent trading session. The company, currently valued at $40.82 Million, closed the recent trade at $0.4815 per share which meant it lost $0 on the day or 3.49% during that session. The BNGO stock price is -876.12% off its 52-week high price of $4.7 and 48.08% above the 52-week low of $0.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.78 Million shares traded. The 3-month trading volume is 9.21 Million shares.
Bionano Genomics, Inc. (NASDAQ:BNGO) trade information
Sporting 1.81% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the BNGO stock price touched $0.535 or saw a rise of 11.96%. Year-to-date, Bionano Genomics, Inc. shares have moved -62.02%, while the 5-day performance has seen it change 4.67%. Over the past 30 days, the shares of Bionano Genomics, Inc. (NASDAQ:BNGO) have changed 4.9%. Short interest in the company has seen 4.74 Million shares shorted with days to cover at 0.51.
Bionano Genomics, Inc. (BNGO) estimates and forecasts
Figures show that Bionano Genomics, Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -56.48% over the past 6 months, with this year growth rate of -75.79%, compared to 9.3% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 87.3% and 86.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be -31.9%.
3 analysts offering their estimates for the company have set an average revenue estimate of $880Million for the current quarter. 3 have an estimated revenue figure of $1.85 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $2.17 Million and $3.31 Million respectively for this quarter and the next, and analysts expect sales will grow by -59.5% for the current quarter and -44.2% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest -8.2% while over the next 5 years, the company’s earnings are expected to increase by 0%.
Bionano Genomics, Inc. (NASDAQ:BNGO)’s Major holders
Insiders own 10.41% of the company shares, while shares held by institutions stand at 11.26% with a share float percentage of 12.56%. Investors are also buoyed by the number of investors in a company, with Bionano Genomics, Inc. having a total of 21 institutions that hold shares in the company. The top two institutional holders are Bank Julius Baer & Co. Ltd, Zurich with over 452.92 Thousand shares worth more than $206.08 Thousand. As of March 30, 2020, Bank Julius Baer & Co. Ltd, Zurich held 0.54% of shares outstanding.
The other major institutional holder is Geode Capital Management, LLC, with the holding of over 246.97 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $112.37 Thousand and represent 0.29% of shares outstanding.